Necrolytic migratory erythema
(Redirected from Glucagonoma syndrome)
Necrolytic migratory erythema | |
---|---|
Synonyms | N/A |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Erythematous rash, blistering, crusting |
Complications | Infection, scarring |
Onset | |
Duration | |
Types | N/A |
Causes | Glucagonoma |
Risks | |
Diagnosis | Clinical diagnosis, biopsy |
Differential diagnosis | N/A |
Prevention | N/A |
Treatment | Surgical resection, octreotide, nutritional support |
Medication | N/A |
Prognosis | |
Frequency | Rare |
Deaths | N/A |
Necrolytic migratory erythema (NME) is a distinctive skin rash that is often associated with the glucagonoma syndrome, a rare pancreatic tumor that secretes excessive amounts of the hormone glucagon.
Presentation
NME is characterized by erythematous patches that evolve into blistering and crusting lesions. These lesions typically appear in areas subject to friction or pressure, such as the groin, buttocks, perineum, and lower abdomen. The rash is often pruritic and can be painful.
Pathophysiology
The exact mechanism of NME is not fully understood, but it is believed to be related to the metabolic effects of excess glucagon, including amino acid deficiency and zinc deficiency. These deficiencies may impair the skin's ability to repair itself, leading to the characteristic lesions.
Diagnosis
Diagnosis of NME is primarily clinical, supported by the presence of a glucagonoma. A biopsy of the skin lesions can help confirm the diagnosis by showing necrolysis of the upper layers of the epidermis.
Treatment
The primary treatment for NME is the surgical removal of the glucagonoma. Medical management may include the use of octreotide, a somatostatin analog that inhibits glucagon secretion. Nutritional support, including amino acid and zinc supplementation, may also be beneficial.
Prognosis
The prognosis of NME depends on the successful treatment of the underlying glucagonoma. Surgical resection of the tumor can lead to resolution of the skin lesions and improvement in symptoms.
See also
References
External links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD